A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 30 Jun 2016 New trial record
- 21 Jun 2016 Planned End Date changed from 1 Jun 2015 to 1 Dec 2016.